XML 68 R55.htm IDEA: XBRL DOCUMENT v3.19.2
Earnings per Share - Additional information (Details) - USD ($)
$ / shares in Units, $ in Millions
1 Months Ended 3 Months Ended 9 Months Ended
Dec. 01, 2018
Dec. 01, 2015
Nov. 30, 2018
Nov. 30, 2015
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]                
Impact of restricted shares, restricted share units and performance share units (in shares)         1,700,000 1,700,000 2,100,000 2,100,000
Share-based compensation expense         $ 5 $ 4 $ 13 $ 14
Impact of convertible notes (in shares)         900,000 900,000 800,000 1,000,000.0
Convertible Notes Payable | 7.875% Convertible Notes Due 2026                
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]                
Interest rate         7.875%   7.875%  
Executive Officer                
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]                
Number or shares issuable per performance share unit (in shares) 1     1        
Executive Officer | Performance Shares                
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]                
Exercise price (in usd per share) $ 16.50 $ 10.51            
Executive Officer | Performance Shares | Performance period of October 1, 2018 to September 30, 2021                
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]                
Performance period     3 years          
Shares authorized for grant (in shares)     500,000          
Executive Officer | Performance Shares | Performance period of October 1, 2018 to September 30, 2021 | Minimum                
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]                
Performance-based vesting percentage             0.00%  
Executive Officer | Performance Shares | Performance period of October 1, 2018 to September 30, 2021 | Maximum                
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]                
Performance-based vesting percentage             200.00%  
Executive Officer | Performance Shares | Performance period of October 1, 2018 to September 30, 2021 | Performance Objective One                
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]                
Award vesting rights percentage             50.00%  
Executive Officer | Performance Shares | Performance period of October 1, 2018 to September 30, 2021 | Performance Objective Two                
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]                
Award vesting rights percentage             50.00%  
Executive Officer | Performance Shares | Performance period of October 1, 2015 to September 30, 2018                
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]                
Performance period       3 years        
Executive Officer | Restricted Share Units (RSUs)                
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]                
Exercise price (in usd per share)   $ 10.51            
Shares granted (in shares)     400,000 500,000        
Vesting period 3 years 3 years